IVERIC bio Inc.

ISEE | NASDAQ

Price Alert Chart Builder DCF Calculator

$39.95

+$0.15 (+0.38%)

At close: Jul 10, 2023, 04:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $5.51B

Enterprise Value $5.01B

Beta 1.10

Average Volume N/A

Shares Outstanding (Diluted) 137.09M

Shares Change YoY 15.44%

Institutional Ownership N/A

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 6.2%

1Y CAGR (ann.) 257.0%

5Y CAGR (ann.) 70.4%

All-Time CAGR 4.4%

Valuation

PE Ratio -22.96

Forward PE N/A

PEG Ratio 0.71

Forward PEG 0.71

PS Ratio N/A

Forward PS N/A

PB Ratio 11.55

P/FCF Ratio -31.02

P/Adj. FCF Ratio -26.14

P/OCF Ratio -29.59

EV/Sales N/A

EV/EBIT -22.53

EV/EBITDA -21.66

EV/FCF -28.19

Earnings Yield -4.4%

FCF Yield -3.2%

Adj. FCF Yield -3.8%

Financial Health

Net Cash $502.16M

Total Debt $97.76M

Cash & Short-Term Investments $599.92M

Total Assets $613.41M

Current Ratio 18.63

Quick Ratio 18.63

Debt / Equity Ratio 0.18

Debt / EBITDA -0.42

Debt / FCF -0.55

OCF / Debt -1.81

Interest Coverage -83.88

Altman Z-Score 22.15

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -18.7%

Returns

Return on Assets -26.4%

Return on Equity -39.3%

Return on Invested Capital -28.5%

Return on Capital Employed -30.1%

Return on Tangible Assets -26.4%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -17.6%

EPS CAGR 3Y -22.0%

EPS CAGR 5Y -82.1%

EPS CAGR 10Y 30.4%

FCF CAGR 3Y -41.2%

FCF CAGR 5Y -35.1%

FCF CAGR 10Y -18.0%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 24

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date May 7, 2024

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $32.75

Price Target Upside -18.0%

Cash Flow

Operating Cash Flow $-176.85M

Free Cash Flow $-177.71M

Adj. Free Cash Flow $-210.89M

FCF Per Share -$1.36

OCF Per Share -$1.35

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-229.08M

EBITDA $-231.35M

Net Income $-220.32M

EPS (Diluted) -$1.74

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A